期刊
JACC-CARDIOVASCULAR IMAGING
卷 11, 期 8, 页码 1150-1172出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jcmg.2018.06.004
关键词
cardio-oncology; cardiovascular magnetic resonance; tissue characterization
资金
- National Institute of Health [R01CA199167, R01CA167821, R01HL118740]
- ILSI Health and Environmental Sciences Institute
Patients with or receiving potentially cardiotoxic treatment for cancer are susceptible to developing decrements in left ventricular mass, diastolic function, or systolic function. They may also experience valvular heart disease, pericardial disease, or intracardiac masses. Cardiovascular magnetic resonance may be used to assess cardiac anatomy, structure, and function and to characterize myocardial tissue. This combination of features facilitates the diagnosis and management of disease processes in patients with or those who have survived cancer. This report outlines and describes prior research involving cardiovascular magnetic resonance for assessing cardiovascular disease in patients with or previously having received treatment for cancer. (c) 2018 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据